| Document Date: 2014-10-01 21:56:23
Open Document File Size: 68,87 KBShare Result on Facebook
Company Novartis Pharmaceuticals Australia Pty Ltd / TSI / TIP / PBAC / ITT / / Country Australia / / Currency USD / / Event FDA Phase / / IndustryTerm age / inhalation solution / cystic fibrosis requiring long-term management / / MedicalCondition Pseudomonas / disease / P. aeruginosa infection / chronic pseudomonal infection / proven and chronic Pseudomonas / pulmonary exacerbations / proven Pseudomonas / chronic pulmonary Pseudomonas / cystic fibrosis requiring long-term management / Dysphonia / greater cough / P. aeruginosa respiratory infection / P. aeruginosa infections / aeruginosa infection / infection / cough / cystic fibrosis / / MedicalTreatment antibiotics / / Organization National Science Foundation / TIP administration / Drug administration / Listing Requested and PBAC’s View Authority / / Position Governor / Trial ID/ First Protocol title/ Publication title author / / Product Samsung S73 Digital Camera / Tobi / Tobramycin / Konstan / / URL http /
SocialTag |
Microsoft WordTobramycin Novartis PSD March 2013 FINAL.docx